Theorem Clinical Research

Archives

Choose a date range

From To

Choose one or more categories

Categories:



Show only original CenterWatch stories

 


PharmAthene awarded $28.1M to develop thermostable anthrax vaccine

Thursday, September 11, 2014 01:36 PM

PharmAthene, an Annapolis, Md.-based biodefense company developing medical countermeasures against biological and chemical threats, has announced the National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, has awarded the company a contract, valued at up to $28.1 million if all contract options are exercised, for the development of a next-generation anthrax vaccine based on the company's proprietary rPA anthrax vaccine technology platform.

More... »


NICE to seek greater access to clinical trial data when appraising drugs

Thursday, September 11, 2014 01:32 PM

NICE will ask for access to clinical trial data from European regulatory authorities if pharmaceutical companies fail to supply all relevant data. The move follows calls for increasing transparency from pharma companies and comes after Roche was criticized for its handling of data for the pandemic flu drug Tamiflu.

More... »


Report: Psoriatic arthritis market will reach more than $3.5B in 2023

Thursday, September 11, 2014 01:28 PM

The market for psoriatic arthritis (PsA) therapies will grow nearly 66%, increasing to $3.7 billion in 2023, due to the continued uptake of premium-price biologics and novel therapies expected to launch during the 2013 to 2023 forecast period, according to Burlington, Mass.-based Decision Resources Group.

More... »

Seattle Genetics, Genmab enter into antibody-drug conjugate collaboration

Thursday, September 11, 2014 01:20 PM

Seattle Genetics, a biotech company focused on development and commercialization of innovative antibody-based therapies for cancer, and Genmab, a Denmark-based international biotech company specializing in differentiated human antibody therapeutics for cancer, have entered into an additional antibody-drug conjugate (ADC) collaboration.

More... »

PMG Research forms its 11th clinical site

Wednesday, September 10, 2014 03:07 PM

PMG Research (PMG), an integrated network of clinical research facilities in the southeastern U.S., has established its 11th clinical research site, PMG Research of Rocky Mount. PMG Research has assumed ownership and operation of the clinical research department at Boice-Willis Clinic in Rocky Mount, N.C., further expanding PMG’s presence in eastern North Carolina. This new site enhances PMG’s access to an additional 130,000 patients.

More... »

Survey reveals knowledge gaps among Parkinson's patients and caregivers

Wednesday, September 10, 2014 03:04 PM

Information and specialized care can help patients become more engaged in their own treatment and in the Parkinson's disease (PD) community, according to a recent online survey of more than 1,500 PD patients, caregivers and physicians conducted by Harris Poll on behalf of the Michael J. Fox Foundation and AbbVie.

More... »

Report: clinical trials will continue to play a key role in oncology device market

Wednesday, September 10, 2014 03:03 PM

The U.S. interventional oncology device market will see strong growth, reaching a value of $760 million by 2023, according to Decision Resources Group. Rising cancer incidence rates, combined with the ineffectiveness of chemotherapy and demand for less invasive procedures, will support interventional oncology device uptake.

More... »

Almac’s releases clinical supply chain management service

Wednesday, September 10, 2014 03:02 PM

Almac, a contract development and manufacturing organization headquartered in Craigavon, Northern Ireland, has released a new clinical Supply Chain Management (SCM) service as a response to growth in demand for biologics and global trials.

More... »

NeuroVive Pharmaceutical, Oncore Biopharma ink $150M agreement

Wednesday, September 10, 2014 03:01 PM

NeuroVive Pharmaceutical, a Swedish mitochondrial medicine company, has signed an exclusive global out-licensing agreement with the Pennsylvania-based OnCore BioPharma for the development and commercialization of NeuroVive’s drug candidate NVP018 for oral treatment of chronic hepatitis B virus (HBV) infection. The agreement could give NeuroVive a total of $150 million in conditional milestone payments, plus royalties on future drug sales.

More... »

Livongo Health launched

Wednesday, September 10, 2014 03:00 PM

Livongo Health, a California-based consumer digital health company, has launched with a vision to empower people with chronic conditions to live better through the combined power of technology, real-time personalized information and support from a chosen care team.

More... »

CenterWatch Drugs in Clinical Trials
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 15

WIRB-Copernicus Group acquires New England IRB

BBK Worldwide secures $3 million in private ἀnancingto accelerate its global and technological expansion

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

July

IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs